Cat.#: ASSD-137
| Description | Chemokine CCR2 covalent negative allosteric modulator (NAM) binds intracellularly and forms a covalent bond with one of three proximal cysteine residues of CCR2. Apparent pKi values at CCR2 are 8.7 and 9.2 (after 4h), where a Ki shift indicates a covalent mode of action. |
| Size | 50 μg |
| Chemical Name | 2-[[4-[4-Chloro-2-[[4-chloro-3-(trifluoromethyl)phenyl]sulfonylamino]phenoxy]benzoyl]amino]ethyl thiocyanate |
| Molecule Weight | 590.4 |
| Molecular formula | C23H16Cl2F3N3O4S2 |
| PubChem identifier | 162666730 |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-176 | Rhodamine B isothiocyanate (AC176) | 100 mg, 500 mg | inquiry |
| ASSD-124 | Fluorescent β2 antagonist [(S)-propranolol-green] (AC124) | 500 μg | inquiry |
| ASSD-163 | Ponceau S sodium salt (AC163) | 25 g | inquiry |
| ASSD-134 | FITC Phalloidin (AC134) | 300 tests, 100μg | inquiry |
| ASSD-141 | MTT (AC141) | 500 mg, 1 g | inquiry |
| ASSD-168 | Indo-1 AM (AC168) | 1 mg | inquiry |
| ASSD-177 | Fluorescein 5-Maleimide (AC177) | 25 mg | inquiry |
| ASSD-202 | 5(6)-Carboxytetramethylrhodamine (AC202) | 100 mg, 250 mg | inquiry |
| ASSD-120 | Fluorescent adenosine antagonist [XAC] (AC120) | 500 μg | inquiry |
| ASSD-204 | 7-Diethylamino-3-[N-(2-maleimidoethyl)carbamoyl]coumarin (AC204) | 1 mg, 5 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.